Clinical Trial

TBE Zone 0/1 PMS in Japan

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this surveillance is to confirm the safety and efficacy of TBE under actual use in the Zone 0/1 lesion on post-marketing usage conditions.
Trial Details
NCT Number NCT07691931
Lead Sponsor W.L.Gore & Associates
Collaborators: CMIC Co, Ltd. Japan
Conditions Aneurysm of Aorta, Thoracic, Dissection of Aorta, Thoracic, Trauma
Enrollment 75 participants
Start Date 2026-09
Primary Completion 2035-09 (estimated)
Study Completion 2035-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-09